Prior to Kymera, Dr. Chadwick served as Senior Vice President, Head of Global Development Office at Takeda Pharmaceuticals. During his time there, he headed Regulatory Affairs, as well as managed Development Operations, Drug Safety and Clinical Supply Chain . Before Takeda, Dr. Chadwick was Group Vice President and Head of Clinical Development Operations at Shire Pharmaceuticals. Earlier in his career, Dr. Chadwick held a number of senior development roles with broad responsibilities including program management, development operations, regulatory affairs, drug safety, biostatistics and data management, working in The Medicines Company, Synta Pharmaceuticals, Vertex Pharmaceuticals, Parexel International and Glaxo Group Research. Dr. Chadwick has been involved in multiple successful global approvals across numerous therapeutic areas. Dr. Chadwick previously served as chairman of the Board of Directors at Accumulus Synergy, who are leading the charge to develop transformative data exchange platform designed to enhance how biopharmaceutical innovators and regulators bring safe and effective medicines to patients faster. He earned his MS and PhD in Statistics from the University of London and a BS in Mathematics from Demontfort University in the UK.